Detailed Information on Publication Record
2020
PHAGOCYTOSIS-INFLAMMATION CROSSTALK IN SEPSIS: NEW AVENUES FOR THERAPEUTIC INTERVENTION
HORTOVÁ KOHOUTKOVÁ, Marcela, Federico TIDU, Marco DE ZUANI, Vladimír ŠRÁMEK, Martin HELÁN et. al.Basic information
Original name
PHAGOCYTOSIS-INFLAMMATION CROSSTALK IN SEPSIS: NEW AVENUES FOR THERAPEUTIC INTERVENTION
Authors
HORTOVÁ KOHOUTKOVÁ, Marcela (203 Czech Republic), Federico TIDU (380 Italy), Marco DE ZUANI, Vladimír ŠRÁMEK (203 Czech Republic, belonging to the institution), Martin HELÁN (203 Czech Republic, belonging to the institution) and Jan FRIC (203 Czech Republic)
Edition
Shock, Philadelphia, Lippincott Williams & Wilkins, 2020, 1073-2322
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30212 Surgery
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.454
RIV identification code
RIV/00216224:14110/20:00118327
Organization unit
Faculty of Medicine
UT WoS
000619501000004
Keywords in English
Monocyte; phagocytosis; sepsis; signaling
Tags
International impact, Reviewed
Změněno: 4/3/2021 07:49, Mgr. Tereza Miškechová
Abstract
V originále
Phagocytosis is a complex process by which cells within most organ systems remove pathogens and cell debris. Phagocytosis is usually followed by inflammatory pathway activation, which promotes pathogen elimination and inhibits pathogen growth. Delayed pathogen elimination is the first step in sepsis development and a key factor in sepsis resolution. Phagocytosis thus has an important role during sepsis and likely contributes to all of its clinical stages. However, only a few studies have specifically explored and characterized phagocytic activity during sepsis. Here, we describe the phagocytic processes that occur as part of the immune response preceding sepsis onset and identify the elements of phagocytosis that might constitute a predictive marker of sepsis outcomes. First, we detail the key features of phagocytosis, including the main receptors and signaling hallmarks associated with different phagocytic processes. We then discuss how the initial events of phagosome formation and cytoskeletal remodeling might be associated with known sepsis features, such as a cytokine-driven hyperinflammatory response and immunosuppression. Finally, we highlight the unresolved mechanisms of sepsis development and progression and the need for cross-disciplinary approaches to link the clinical complexity of the disease with basic cellular and molecular mechanisms.